GenAhead Bio licenses CRISPR/Cas9 from Broad Institute
GenAhead Bio Incorporated ("GenAhead") announced today the signing of a non-exclusive commercial research tool and services license agreement to CRISPR / Cas9 genome editing technology from the Broad Institute of MIT and Harvard. GenAhead began operations in 2018 as a spin-out from Takeda Pharmaceutical Company Limited and has since leveraged the latest CRISPR / Cas9 […]
Our highly efficient genome editing technology, CRISPR-SNIPER, was featured in the following article in "Bioradiations"
Our highly efficient genome editing technology, CRISPR-SNIPER, was featured in the following article in "Bioradiations". Title of the article: “Modernizing Gene Editing Detection with Droplet Digital PCR”
Research Project for the Promotion of Innovative Drug Development for Emerging and Re-emerging Infectious Diseases
We are pleased to announce that our proposal has been selected by the Japan Agency for Medical Research and Development (AMED) for the third round of the "Research Project for Promoting Innovative Drug Development for Emerging and Re-emerging Infectious Diseases" in FY2022. The press release can be found here
GenAhead Bio Selected as a Grantee for the Fifth Business Restructuring Subsidy
We are pleased to announce that GenAhead Bio has been selected as a recipient of the "Business Restructuring Subsidy" by the Small and Medium Enterprise Agency. Click here to see the press release.
NEDO's "Research and Development Start-up Support Program" for FY2022
We are pleased to announce that GenAhead Bio has been selected by the New Energy and Industrial Technology Development Organization (NEDO) as a recipient of the "Research and Development Start-up Support Program". Click here for the press release.
GenAhead Bio Selected as a Grantee for the 2021 Invention Research Incentive Program
We are pleased to announce that GenAhead Bio has been selected as a recipient of the 2021 Invention Research Encouragement Grant from the Japan Society for the Advancement of Inventions. Click here for the press release
The Chemical Daily Co., Ltd. made a bief report of our company
The article was published in the January 22, 2021 issue of The Chemical Daily.